Satellos Bioscience’s strategy is to advance its scientific platform through biopharmaceutical partnerships. We are seeking discussions with companies who have franchise interests in Duchenne Muscular Dystrophy, musculoskeletal or neurodegeneration diseases, and aging.
Satellos is establishing a powerful discovery platform based upon a disruptive scientific idea. We are keen to engage with visionary venture capital and strategic investors whose passion is building new companies around bold, game-changing concepts.
For investment or general inquiry, please contact Frank Gleeson at:
65 Front Street East, Suite 201
Toronto, ON M5E 1B5